title: [ASCO/CAP guidelines and recommendations on hormonal receptor testing in breast cancer].
authors.forename: Tao
authors.initials: T
authors.lastname: Wang
authors.forename: Ze-Fei
authors.initials: ZF
authors.lastname: Jiang
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000737:chemistry* / Q000628:therapy; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000737:chemistry / Q000628:therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008495:Medical Oncology / Q000592:standards; D017410:Practice Guidelines as Topic; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*; D012955:Societies, Medical; D013629:Tamoxifen / Q000627:therapeutic use; D014481:United States
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen